Zhejiang Dayang Biotech Group Co (003017) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.001x

Based on the latest financial reports, Zhejiang Dayang Biotech Group Co (003017) has a cash flow conversion efficiency ratio of 0.001x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥638.25K ≈ $93.40K USD) by net assets (CN¥1.10 Billion ≈ $161.25 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Zhejiang Dayang Biotech Group Co - Cash Flow Conversion Efficiency Trend (2013–2024)

This chart illustrates how Zhejiang Dayang Biotech Group Co's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Zhejiang Dayang Biotech Group Co (003017) financial obligations for a breakdown of total debt and financial obligations.

Zhejiang Dayang Biotech Group Co Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Zhejiang Dayang Biotech Group Co ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Hemisphere Properties India Limited NSE:HEMIPROP	0.000x
BTQ Technologies Corp. NEO:BTQ	N/A
Shandong Teamgene Technology Co. Ltd. A SHG:603151	N/A
Orthopediatrics Corp NASDAQ:KIDS	0.030x
Cabio Biotech Wuhan Co Ltd SHG:688089	0.034x
Pitti Engineering Limited NSE:PITTIENG	0.102x
Chieftek Precision Co Ltd TW:1597	0.009x
Lootom Telcovideo Network Wuxi Co Ltd SHE:300555	-0.025x

Annual Cash Flow Conversion Efficiency for Zhejiang Dayang Biotech Group Co (2013–2024)

The table below shows the annual cash flow conversion efficiency of Zhejiang Dayang Biotech Group Co from 2013 to 2024. For the full company profile with market capitalisation and key ratios, see Zhejiang Dayang Biotech Group Co (003017) total market value.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥1.05 Billion ≈ $154.11 Million	CN¥66.19 Million ≈ $9.69 Million	0.063x	-65.26%
2023-12-31	CN¥1.01 Billion ≈ $147.53 Million	CN¥182.42 Million ≈ $26.69 Million	0.181x	+93.97%
2022-12-31	CN¥985.05 Million ≈ $144.14 Million	CN¥91.89 Million ≈ $13.45 Million	0.093x	+362.87%
2021-12-31	CN¥990.71 Million ≈ $144.97 Million	CN¥-35.16 Million ≈ $-5.14 Million	-0.035x	-130.23%
2020-12-31	CN¥958.13 Million ≈ $140.20 Million	CN¥112.49 Million ≈ $16.46 Million	0.117x	-48.29%
2019-12-31	CN¥498.09 Million ≈ $72.89 Million	CN¥113.09 Million ≈ $16.55 Million	0.227x	+158.02%
2018-12-31	CN¥440.62 Million ≈ $64.48 Million	CN¥38.77 Million ≈ $5.67 Million	0.088x	-38.90%
2017-12-31	CN¥337.71 Million ≈ $49.42 Million	CN¥48.64 Million ≈ $7.12 Million	0.144x	-60.97%
2016-12-31	CN¥229.35 Million ≈ $33.56 Million	CN¥84.63 Million ≈ $12.38 Million	0.369x	+58.13%
2015-12-31	CN¥209.76 Million ≈ $30.70 Million	CN¥48.95 Million ≈ $7.16 Million	0.233x	-20.42%
2014-12-31	CN¥196.87 Million ≈ $28.81 Million	CN¥57.73 Million ≈ $8.45 Million	0.293x	-40.03%
2013-12-31	CN¥187.42 Million ≈ $27.43 Million	CN¥91.64 Million ≈ $13.41 Million	0.489x	--

About Zhejiang Dayang Biotech Group Co

SHE:003017 China Chemicals

Market Cap

$394.81 Million

CN¥2.70 Billion CNY

Market Cap Rank

#13754 Global

#4333 in China

Share Price

CN¥32.12

Change (1 day)

+1.07%

52-Week Range

CN¥24.18 - CN¥36.52

All Time High

CN¥39.37